Mark Mazak, PA
Physician Assistant · Lakewood, NJNPI 1285748897
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $13,830 of the $21,033 with a category attached, or 65.8%. Sun Pharmaceutical Industries Inc. accounts for 72.5% of it on its own, with 25 other manufacturers making up the rest. Reporting peaked in 2023 at $7,378 and has fallen 71.2% since, to $2,125 in 2025. Among physician assistant clinicians in NJ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 348 payments — averaging $60.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sun Pharmaceutical Industries Inc.$15K
- Johnson & Johnson$1K
- Journey Medical Corporation$763
- AbbVie$622
- Dermavant Sciences, Inc.$610
- Arcutis Biotherapeutics, Inc.$404
- plus $2K from 20 others
What the payments were for
- Consulting fees$7504%
- Speaking & faculty fees$13,83066%
- Travel & lodging$3482%
- Food & beverage$5,60027%
- Education$5062%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sun Pharmaceutical Industries Inc. | 36 | $15,254 |
| Johnson & Johnson | 55 | $1,144 |
| Journey Medical Corporation | 2 | $763 |
| AbbVie | 46 | $622 |
| Dermavant Sciences, Inc. | 56 | $610 |
| Arcutis Biotherapeutics, Inc. | 51 | $404 |
| E.r. Squibb & Sons, L.L.C. | 15 | $364 |
| Sanofi | 8 | $248 |
| Amgen | 4 | $190 |
| Mayne Pharma Commercial LLC | 19 | $181 |
| UCB, Inc. | 6 | $161 |
| EPI Health, LLC | 5 | $151 |
| Lilly USA, LLC | 8 | $137 |
| Novartis | 7 | $136 |
| Galderma Laboratories, L.p. | 3 | $129 |
| Organon | 6 | $89 |
| Sanofi-aventis U.S. LLC | 1 | $80 |
| LEO Pharma Inc. | 5 | $80 |
| VYNE Pharmaceuticals Inc. | 1 | $53 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 3 | $51 |
| Incyte Corporation | 3 | $50 |
| Regeneron Healthcare Solutions, Inc. | 2 | $37 |
| Organogenesis Inc. | 2 | $35 |
| Pfizer | 2 | $34 |
| Boehringer Ingelheim | 1 | $15 |
| Verrica Pharmaceuticals Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$21,033 in reported general payments places this provider in the 95th percentile of 2,726 physician assistant providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 41 | $154,339 |
| Humira PenAdalimumab | 14 | $93,389 |
| Cosentyx (2 Syringes)Secukinumab | 12 | $85,098 |
| OtezlaApremilast | 14 | $76,541 |
| Doxycycline Ir-DrDoxycycline Monohydrate | 16 | $24,596 |
| Acitretin | 17 | $22,037 |
| Clobetasol Propionate | 132 | $6,825 |
| Metronidazole | 66 | $5,093 |
| Ketoconazole | 212 | $4,213 |
| Halobetasol Propionate | 110 | $3,828 |
| Triamcinolone Acetonide | 241 | $2,658 |
| Clindamycin Phosphate | 57 | $2,510 |
| Fluorouracil | 16 | $1,249 |
| Hydrocortisone | 124 | $1,091 |
| Doxycycline Hyclate | 74 | $1,012 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| NovartisCosentyx (2 Syringes) | $136 | $85,09812 claims |
| AmgenOtezla | $190 | $76,54114 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,726 physician assistant providers in New Jersey.
Other physician assistant in Lakewood
- Alexa HetzelEast Windsor$588K
- Nicole Schmid DavisHamilton$148K
- Todd NewmanHoboken$73K
- Patrick McGinnShrewsbury$72K
- Tatiana Dell'aquilaNutley$43K
- Nicole ColucciRiverdale$36K
- Salvatore SciurbaMiddletown$25K
- Jacqueline CristiniEdison$22K
- Andrea BarkerPrinceton$21K
- Andrea StuartHackensack$21K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.